Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income -577.36 K-763.87 K-867.83 K-376.14 K-315.96 K -2.32 M Non-Operating Income, Total 1.12 M1.13 M392.61 K240.05 K221.76 K 1.98 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.12 M1.13 M392.61 K240.05 K221.76 K 1.98 M Unusual income/expense ————— — Pretax income 542.33 K362.58 K-475.22 K-136.09 K-94.19 K -342.92 K Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 542.33 K362.58 K-475.23 K-136.09 K-94.19 K -342.92 K Discontinued operations ————— — Net income 542.33 K362.58 K-475.23 K-136.09 K-94.19 K -342.92 K Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 542.33 K362.58 K475.23 K-1.09 M94.19 K -154.53 K Basic earnings per share (Basic EPS) 0.030.03-0.03-0.01-0.01 -0.02 Diluted earnings per share (Diluted EPS) 0.030.03-0.03-0.01-0.01 -0.02 Average basic shares outstanding 6.42 M6.42 M6.42 M6.28 M2.24 M — Diluted shares outstanding 6.42 M6.42 M6.42 M6.42 M2.24 M — EBITDA ————— — EBIT -577.36 K-763.87 K-867.83 K-376.14 K-315.96 K -2.32 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —